Jupiter Neurosciences, Inc. (JUNS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 35.32M |
| Enterprise Value | 36.85M |
| P/E Ratio | -0.63 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 152.51 |
| Price/Book Ratio | -2.15 |
| Enterprise/Revenue | 213.58 |
| Enterprise/EBITDA | -0.96 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -226.91 |
| Operating Margin | -230.76 |
| Return On Assets | -2.32 |
| Return On Equity | 11.41 |
| Revenue | 21,796 |
| Revenue/Share | 0 |
| Gross Profit | 17,565 |
| EBITDA | -8.58M |
| Net Income | -8.64M |
| Diluted EPS | -0.25 |
| Total Cash | 2.36M |
| Total Cash/Share | 0.07 |
| Total Debt | 4.83M |
| Total Debt/Equity | -1.74 |
| Current Ratio | 0.51 |
| Book Value Per Share | -0.08 |
| 52-Week Change | -90.41 |
| 52-Week High | 1.85 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 0.25 |
| Moving Average 200 Days | 0.72 |
| Average Volume | 7.35M |
| Shares Outstanding | 36.35M |
| % Held by Institutions | 5.4 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |